Costs and utility of tests in the evaluation of the pediatric patients with syncope

Progress in Pediatric Cardiology

Volumn 13, Issue 2, 2001, Pages 139-149

  Steinberg, Leonard A ^a   Knilans, Timothy K ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cost effectiveness; Diagnostic testing; Pediatrics; Syncope

Indexed keywords

ARTICLE; COST; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIAGNOSTIC TEST; ELECTROCARDIOGRAM; EVALUATION; HIGH RISK PATIENT; HUMAN; NEUROLOGIC EXAMINATION; PEDIATRICS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH; SYNCOPE;

EID: 0034945815     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1058-9813(01)00097-2     Document Type: Article

References (99)

1. Syncope of unknown origin. The need for a more cost-effective approach to its diagnostic evaluation
2. The economic burden of unrecognized vasodepressor syncope
3. Syncope in children and adolescents
4. A retrospective analysis of the cost-effective workup of syncope in children
5. The high cost of syncope: cost implications of a new insertable loop recorder in the investigation of recurrent syncope
6. Diagnosing syncope. Part 1: Value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians
7. Evaluation and outcome of emergency room patients with transient loss of consciousness
8. Evaluation and outcome of patients with syncope
9. Syncope: a retrospective study of 101 hospitalized patients
10. A prospective evaluation of pediatric patients with syncope
11. Syncope in childhood
12. What is the yield of screening echocardiography in pediatric syncope?
13. Syncope in children
14. Ambulatory arrhythmia screening in symptomatic children and young adults: comparative effectiveness of Holter and telephone event recordings
15. Diagnosing syncope. Part 2: Unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians [see comments]
16. Diagnostic utility of memory equipped transtelephonic monitors
17. Detection of arrhythmia: limited usefulness of patient activated recording devices
18. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope
19. Cardiac loop ECG recording: a new non-invasive diagnostic test in recurrent syncope
20. Detection of arrhythmias: use of a patient-activated ambulatory electrocardiogram device with a solid-state memory loop
21. Utility and cost of event recorders in the diagnosis of palpitations, presyncope, and syncope
22. The etiology of syncope in patients with negative tilt table and electrophysiological testing
23. Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative non-invasive and invasive testing
24. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators
25. Echocardiography in the evaluation of patients with syncope [see comments]
26. Echocardiography in the diagnostic evaluation of syncope
27. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Clinical Application of Echocardiography). Developed in colloboration with the American Society of Echocardiography
28. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes
29. Prospective echocardiographic screening for coronary artery anomalies in 1360 elite competitive athletes
30. Head-up tilt: a useful test for investigating unexplained syncope
31. Tilt table testing for assessing syncope. American College of Cardiology
32. Head-upright tilt table testing in children with unexplained syncope
33. Tilt testing for the evaluation of unexplained syncope
34. Methodology of head-up tilt testing in patients with unexplained syncope [see comments]
35. Specificity of head-up tilt testing in adolescents: effect of various degrees of tilt challenge in normal control subjects
36. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or pre-syncope
37. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope [see comments]
38. Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin [see comments]
39. Comparison of sensitivity and specificity of tilt protocols with and without isoproterenol in children with unexplained syncope
40. Head-up tilt test: a highly sensitive, specific test for children with unexplained syncope
41. Head-up tilt test in patients with high pretest likelihood of neurally mediated syncope: an approximation to the 'real sensitivity' of this testing
42. Evaluation of syncope by upright tilt testing with isoproterenol. A non-specific test
43. Heart rate and blood pressure response to upright tilt in young patients with unexplained syncope
44. The use of head-upright tilt table testing in the evaluation and management of syncope in children and adolescents
45. Tilt table testing in the evaluation and management of athletes with recurrent exercise-induced syncope [see comments]
46. Cardiovascular dynamics during orthostasis and the influence of intravascular instrumentation
47. Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons
48. Variations in expression and treatment of transient neurocardiogenic instability
49. Tilt table evaluation for control pediatric patients: comparison with symptomatic patients
50. Neurally mediated syncope in children: results of tilt testing, treatment, and long-term follow-up
51. Tilt test for diagnosis of unexplained syncope in pediatric patients
52. Sensitivity and specificity of the tilt table test in young patients with unexplained syncope
53. Syncope recurrence in children: relation to tilt-test results
54. The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin
55. Tilting towards a diagnosis in recurrent unexplained syncope
56. The head-up tilt table test in patients with syncope of unknown origin
57. Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome [see comments]
58. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study
59. Prospective evaluation of day-to-day reproducibility of upright tilt-table testing in unexplained syncope
60. Reproducibility of head upright tilt table test results in patients with syncope
61. Reproducibility of head-up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease
62. Immediate reproducibility of the tilt-table test in adults with unexplained syncope
63. Reproducibility of a symptomatic response to upright tilt in young patients with unexplained syncope
64. Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope
65. Evaluation of recurrent pediatric syncope: role of tilt table testing
66. Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope
67. Syncope associated with exercise, a manifestation of neurally mediated syncope
68. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause
69. Indications, methodology, and classification of results of tilt-table testing
70. Causes of syncope in children: a prospective study
71. Exercise-induced neurocardiogenic syncope
72. Exercise induced vasodepressor syncope
73. Ventricular arrhythmias in children: the validity of exercise stress tests for their diagnosis and management
74. Right ventricular tachycardia: clinical and electrophysiologic characteristics
75. Tachyarrhythmias in young athletes
76. Ventricular tachycardia in a young population without overt heart disease
77. Arrhythmias in children: the influence of exercise and the role of exercise testing
78. Prevalence and prognosis of exercise-induced non-sustained ventricular tachycardia in apparently healthy volunteers
79. Non-invasive evaluation of myocardial ischemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing
80. Role of cardiac electrophysiologic studies in patients with unexplained recurrent syncope
81. Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncope
82. Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing
83. The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by transient bradycardia [see comments]
84. Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and presyncope
85. Evaluation of arrhythmic causes of syncope: correlation between Holter monitoring, electrophysiologic testing, and body surface potential mapping
86. The role of electrophysiologic studies in the management of patients with unexplained syncope
87. The role of electrophysiologic studies in the evaluation of recurrent, unexplained syncope
88. Electrophysiologic studies in patients with unexplained syncope
89. Diagnosis and natural history of syncope and the role of invasive electrophysiologic testing
90. Electrophysiological testing. The final court of appeal for diagnosis of syncope?
91. Clinical and electrophysiological characteristics of ventricular tachycardia in children with normal hearts
92. Induction of ventricular tachycardia during electrophysiologic study after repair of tetralogy of Fallot
93. Electrophysiological studies after the Mustard and Senning operations for complete transposition. Do they have prognostic value?
94. The impact of diagnostic tests in evaluating patients with syncope
95. A prospective evaluation and follow-up of patients with syncope
96. Electroencephalography should not be routine in the evaluation of syncope in adults [see comments]
97. Syncope or seizure? The diagnostic value of the EEG and hyperventilation test in transient loss of consciousness
98. A more cost-effective evaluation of syncope
99. Prospective evaluation of syncope